Flowserve Corp. (FLS) Tops Q3 EPS by 2c; Narrows Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts FLS Hot Sheet
Price: $79.01 -1.67%
Financial Fact:
Provision for income taxes: -52.73M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Financial Fact:
Provision for income taxes: -52.73M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
On Monday, Flowserve Corp. (NYSE: FLS) reported Q3 EPS of $2.07, $0.02 better than the analyst estimate of $2.05. Revenue for the quarter came in at $1.17 billion versus the consensus estimate of $1.16 billion.
Flowserve Corp. sees FY2012 EPS of $8.20-8.70, versus prior guidance of $8.00-8.80 and the consensus of $8.49.
For earnings history and earnings-related data on Flowserve Corp. (FLS) click here.
Flowserve Corp. sees FY2012 EPS of $8.20-8.70, versus prior guidance of $8.00-8.80 and the consensus of $8.49.
For earnings history and earnings-related data on Flowserve Corp. (FLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Dominion Energy (D) Tops Q3 EPS by 9c, Beats on Revenue; Offers FY26 EPS Guidance
- Aurinia Pharmaceuticals (AUPH) Misses Q3 EPS by 1c, Misses on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
